Life Sciences Portfolio (Select Companies)

  • AneuRx

    Stent grafts for abdominal aortic aneurysm

    Acquired by Medtronic (MDT)

  • Arbor Health Care

    Skilled nursing and subacute care centers

    Acquired by Extendicare (EXE)

  • Ardian

    Catheter-based treatment for hypertension

    Acquired by Medtronic

  • Athena Neurosciences

    Pharmaceuticals for neurological diseases

    Acquired by Elan Corp., plc (ELN)

  • Avidia

    New protein structural motifs for treating human disease.

    Acquired by Amgen (AMGN)

  • Cabochon Aesthetics

    A medical device company developing effective scientific solutions for aesthetic procedures.

    Acquired by Ulthera

  • Calithera Biosciences

    A new class of anti-cancer therapeutics based on activation of caspases


  • CardioThoracic Systems

    Devices for minimally-invasive heart surgery

    Acquired by Guidant (GDT)

  • CareMedic

    Revenue cycle management systems for hospitals

    Acquired by Ingenix

  • Catalyst Biosciences

    Developer of engineered proteases as protein therapeutics that attack targets which cause disease.


  • Elcelyx Therapeutics

    Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity

  • Embol-X

    Devices to protect the brain from stroke

    Acquired by Edwards Lifesciences (EW)

  • FoldRx Pharmaceuticals

    Treatments for diseases caused by misfolding of specific proteins

    Acquired by Pfizer

  • ForSight Labs

    Ophthalmic incubator creating unique solutions that address unmet clinical needs in diseases of the eye.


  • ForSight Vision4

    Developer of innovative drug delivery platform for ophthalmic use

    Acquired by Roche

  • ForSight Vision5

    Developing novel device solutions for ophthalmic diseases

    Acquired by Allergan

  • Gliatech

    Devices for the treatment of the nervous system


  • Holaira

    Novel devices for treating lung diseases

  • IPC – The Hospitalist Company

    Hospital-based physician practice management company


  • Medaphis

    Business management services for hospitals/physicians

    Acquired by Per-Sé (PSTI)

  • Miramar

    Device for the treatment of hyperhidrosis and aesthetic complications of excessive sweating


  • Morphotek, Inc.

    Next generation antibodies production technology.

    Acquired by EISIA

  • Mosaic Biosciences

    Platform for tissue engineering using synthetic smart polymers

  • Moximed

    An innovative treatment for patients with osteoarthritis


  • OncoMed Pharmaceuticals Inc.

    Biological therapeutics targeting cancer stem cells


  • Optiscan Biomedical Corporation

    Instruments and sensors for accurate, automated measurement of blood glucose levels


  • Orexigen

    Developer of drug treatments for obesity and related disorders.


  • Perclose

    Suture-mediated vascular closure systems

    Acquired by Abbott Labs (ABT)

  • Principia

    Drug discovery company based on a proprietary chemistry platform that generates novel compounds with enhanced selectivity, high potency and longer duration of effect

  • Promedior Pharmaceuticals

    Therapeutics to treat fibrosis


  • Ra Pharmaceuticals

    Platform for orally available and cell permeable biologics


  • Relievant Medsystems

    Relievant Medsystems is developing a treatment for lower back pain


  • Replidyne

    Drug discovery and development focused on a new class of antibiotics


  • Ribozyme Pharmaceuticals

    RNA-based pharmaceuticals for human disease


  • Scioderm

    Scioderm is focused on the development of innovative drugs for the treatment of chronic diseases of the skin.

    Acquired by Amicus

  • Second Genome

    Microbiome-based therapeutics for infection, inflammation, and metabolic disease

  • Sequana Therapeutics

    Gene discovery via functional genomics

    Acquired by Axys Pharmaceutical (AXPH)

  • SetPoint Medical

    Neuro-modulation platform for the treatment of a variety of acute and chronic diseases


  • SONIC Innovations

    Digital hearing aids


  • Spine Wave, Inc.

    Novel devices for spine surgery


  • Stemgent

    Reagents for stem cell researchers


  • The Foundry

    Medical device incubator


  • Thermage

    Devices for cosmetic aesthetic surgery


  • Third Millenium Healthcare Systems

    Internet-based workflow solutions for healthcare organizations

    Merged with CareMedic

  • Threshold Pharmaceutical, Inc.

    Developing targeted therapies for treatment of cancer.


  • Tragara Pharmaceuticals

    Developer of drugs for the treatment of cancer and inflammation-related diseases.


  • Transcend

    Ophthalmic devices for diseases of the eye


  • Trellis Bioscience

    Platform technology for monoclonal antibody development and production


  • Twelve

    Developing a novel device for treatment of chronic cardiovascular diseases


  • Vapotherm

    Vapotherm is developing high flow therapy for clinically effective respiratory support.

  • Vical

    DNA-based pharmaceuticals for human disease


All portfolio companies

See all portfolio companies